Zobrazeno 1 - 6
of 6
pro vyhledávání: '"P S, Soerensen"'
Autor:
M. Lefort, S. Sharmin, J. B. Andersen, S. Vukusic, R. Casey, M. Debouverie, G. Edan, J. Ciron, A. Ruet, J. De Sèze, E. Maillart, H. Zephir, P. Labauge, G. Defer, C. Lebrun-Frenay, T. Moreau, E. Berger, P. Clavelou, J. Pelletier, B. Stankoff, O. Gout, E. Thouvenot, O. Heinzlef, A. Al-Khedr, B. Bourre, O. Casez, P. Cabre, A. Montcuquet, A. Wahab, J. P. Camdessanché, A. Maurousset, H. Ben Nasr, K. Hankiewicz, C. Pottier, N. Maubeuge, D. Dimitri-Boulos, C. Nifle, D. A. Laplaud, D. Horakova, E. K. Havrdova, R. Alroughani, G. Izquierdo, S. Eichau, S. Ozakbas, F. Patti, M. Onofrj, A. Lugaresi, M. Terzi, P. Grammond, F. Grand’Maison, B. Yamout, A. Prat, M. Girard, P. Duquette, C. Boz, M. Trojano, P. McCombe, M. Slee, J. Lechner-Scott, R. Turkoglu, P. Sola, D. Ferraro, F. Granella, V. Shaygannejad, J. Prevost, D. Maimone, O. Skibina, K. Buzzard, A. Van der Walt, R. Karabudak, B. Van Wijmeersch, T. Csepany, D. Spitaleri, S. Vucic, N. Koch-Henriksen, F. Sellebjerg, P. S. Soerensen, C. C. Hilt Christensen, P. V. Rasmussen, M. B. Jensen, J. L. Frederiksen, S. Bramow, H. K. Mathiesen, K. I. Schreiber, H. Butzkueven, M. Magyari, T. Kalincik, E. Leray
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing–remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control t
Externí odkaz:
https://doaj.org/article/84c3797631444a10b4fb616e78d4bf21
Autor:
Christian A. S. Soerensen, Kristine Appel Uldall Pallesen, Nadja Trier Munk, Christian Vestergaard
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1688-1690 (2021)
Abstract Treatment with Tenutex® should be considered in patients diagnosed with scabies if the first‐line treatment with 5% permethrin fails. Treatment failure with 5% permethrin may be due to tolerance or resistance in scabies mites.
Externí odkaz:
https://doaj.org/article/ac70767b4ffb4aba9eeb26b7bdb54f12
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 2882-2883 (2020)
Abstract Patients who are undergoing treatment with bleomycin and develop prurigo or rash should be suspected of bleomycin‐induced flagellate erythema and treated early with antihistamines, topical, and oral corticosteroids.
Externí odkaz:
https://doaj.org/article/2b721abe272a452eba33c2ca38969d61
Autor:
G. Comi, Patrick Vermersch, Carlo Pozzilli, B. Tackenberg, P. S. Soerensen, Gilles Edan, H.-P. Hartung, M. Delvecchio, Ludwig Kappos, Oscar Fernández, G. Gionvannoni, Sten Fredrikson, Eva Havrdova
Publikováno v:
European Journal of Neurology
European Journal of Neurology, Wiley, 2017, 24 (3), pp.516-522. ⟨10.1111/ene.13236⟩
European Journal of Neurology, 2017, 24 (3), pp.516-522. ⟨10.1111/ene.13236⟩
European Journal of Neurology, Wiley, 2017, 24 (3), pp.516-522. ⟨10.1111/ene.13236⟩
European Journal of Neurology, 2017, 24 (3), pp.516-522. ⟨10.1111/ene.13236⟩
International audience; Background and purpose - Up-to-date information is needed on the extent to which neurologists treating multiple sclerosis (MS) in Europe are integrating rapidly evolving diagnostic criteria, disease-modifying therapies and rec
Autor:
Patrick Vermersch, Sten Fredrikson, Oscar Fernandez, Ludwig Kappos, G. Comi, Eva Havrdova, H.-P. Hartung, M. Delvecchio, Gavin Giovannoni, Gilles Edan, Carlo Pozzilli, P. S. Soerensen, B. Tackenberg
Publikováno v:
European journal of neurology. 25(5)
Background and purpose The European Charcot Foundation supported the development of a set of surveys to understand current practice patterns for the diagnosis and management of multiple sclerosis (MS) in Europe. Part 2 of the report summarizes survey
Autor:
R N, Rosenberg, M, Aminoff, F, Boller, P S, Soerensen, R C, Griggs, M, Hallett, R T, Johnson, C, Kennard, A E, Lang, A J, Lees, R, Lisak, J, Newsom-Davis, T A, Pedley, M E, Selzer, D, Zochodne
Publikováno v:
Neurorehabilitation and neural repair. 15(3)